Oxford, SVB Provide $45MM for Nuvectra

Nuvectra, a neurostimulation medical device company, reached an agreement with Silicon Valley Bank and Oxford Finance, the lenders of its existing credit facility, to secure a second amendment to the company’s loan and security agreement for $45 million.

Oxford Finance Closes $300MM Senior Note Offering

Oxford Finance closed a $300 million senior unsecured note offering by Oxford and Oxford Finance Co-Issuer II, a wholly owned subsidiary of Oxford.

Oxford Finance Provides $20MM Debt Facility to VitalConnect

Oxford Finance closed a $20 million senior secured term loan with VitalConnect, a provider of wearable biosensor technology for wireless monitoring in hospital and remote patient populations.

Marathon Affiliates Provide $30MM Debt Refi to ADMA Biologics

ADMA Biologics entered into a credit agreement for up to $40 million with affiliated entities of Marathon Asset Management. The proceeds were used to refinance an outstanding secured loan with Oxford Finance.

SVB Provides $21MM Term Loan Facility to Selecta Biosciences

Selecta Biosciences entered into a term loan facility for up to $21 million with Silicon Valley Bank, which will be used partly to repay its existing term loan facility with Oxford Finance as agent.

Oxford Provides $40MM Financing for Cerus

Cerus entered into a $40 million amended growth capital credit facility with Oxford Finance, a specialty finance firm that provides senior debt to life sciences and healthcare services companies worldwide.

Dahms Joins Oxford Finance Healthcare Services Team

Peter Dahms, formerly of American Capital, joined Oxford Finance as a senior director of the firm’s healthcare services capital markets team.

Oxford, SVB Close $20MM Facility with Castle Biosciences

Oxford Finance and Silicon Valley Bank closed a $20 million credit facility with Castle Biosciences. The facility encompasses a $15 million term loan and a $5 million line of credit.

Oxford Finance Provides $20MM Cerapedics Senior Debt Facility

Oxford Finance closed a $20 million senior secured term loan with Cerapedics, an orthobiologics company engaged in the development and commercialization of bone graft substitute products for the treatment of orthopedic injuries.

Oxford Finance Provides $50MM Commitment to Entellus Medical

Entellus Medical entered into an agreement with Oxford Finance, as collateral agent and lender, under which Entellus may borrow up to $40 million in term loans and up to $10 million under a revolver.